USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Emerging Therapeutics in the U.S. Colorectal Cancer Markets
29-Apr-2006
North America
Market Research
F205-01-00-00-00
HC01429-NA-MR_05888
Emerging Therapeutics in the U.S. Colorectal Cancer Market is a rapidly progressing field that is set to generate over $2 billion in revenue in the coming years. The market has witnessed unprecedented growth with the launch of a new segment and as a result competition has increased in the cytotoxic market. The dynamics of this market are changing rapidly and the forecast through 2011 highlights the major changes. This study includes patient forecasts, pipeline analysis and individual product revenue forecasts.
Emerging Therapeutics in the U.S. Colorectal Cancer Markets, U.S. Total Market for Colorectal Cancer
Executive Summary
- Executive Summary - Updated 4/2006
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Disease Overview
- Introduction
- Etiology
- Screening
- Diagnosis and Staging
- Treatment Overview
Patient Forecasts
- Incidence and Staging Forecasts
- Patient Forecasts by Line of Therapy
- Unmet Need Population Forecasts
Total Market Forecasts
- Total Market Forecasts - Updated 4/2006
- Market Share Analysis - Updated 4/2006
- Adjuvant Therapy Forecasts - Updated 4/2006
- First-line Therapy Forecasts - Updated 4/2006
- Second and Third-line Therapy Forecasts - Updated 4/2006
General Market Trends
- Industry Challenges
- Market Drivers
- Market Restraints
Frost & Sullivan Awards
- Company of the Year Award
- Product of the Year Award
- Entrepreneurial Company of the Year Award
- Product Differentiation Innovation of the Year Award
- Best Bang for the Buck Award
Overview
Forecasts and Trends
Competitive Analysis
Overview
Angiogenesis Pathway
EGF Pathway
Cell Proliferation/Apoptosis Pathway
Immune Response Pathway
Revenue Forecasts
Competitive Analysis
Decision Support Databases
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
26 Oct 2026 | Global | Technology Research
Game-Changing Innovations Transforming Cardiovascular Care
The study analyzes game-changing technologies transforming cardiovascular care across diagnosis, image-guided intervention, functional assessment, clinical workflow, and longitudinal patient monitoring. The analysis covers five segments: diagnostic imaging and AI-enabled cardiac assessment; interve...
23 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Implantable and Diagnostic Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantable.The issue features advanced medical devices such as single-breath-hold radiotherapy system, transcatheter system f...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.